Companies are halting studies the moment a positive result arises:
Researchers have discovered a sharp increase in the number of studies that are terminated early and argue that drugmakers are halting trials whenever benefits are discovered – and use the premature results as the basis for license applications. As a result, the researchers claim, drugs that are hailed as breakthroughs could be of less benefit or even cause more harm.
Related posts:
- The Texas stampede of physicians
- Medical studies in the media
- Making up drug studies, and is the pressure for results too intense for clinician-scientists?
- Drug seeking in primary care
- Studies of the obvious: It’s easier to get a dermatologist for cosmetic procedures
- Reporting medical studies
- Does Chantix increase suicide risk?
KevinMD.com on Facebook
 
Follow on Twitter  
Subscribe





Comments on this entry are closed.